GeneDx Holdings Corp. Shareholders' Equity
GeneDx Holdings Corp. (WGS) had Shareholders' Equity of $244.22 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-03
- 2026-06-30: Stockholders' Equity Attributable to Parent $244.22M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $254.12M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $308.18M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $292.26M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $244.22M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $254.12M 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $308.18M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $292.26M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $277.13M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $257.40M 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $245.25M 10-Q · filed 2026-08-03 | |
| 2024-09-30 | $204.50M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $194.04M 10-Q · filed 2025-10-28 | |
| 2024-03-31 | $207.22M 10-Q · filed 2025-07-29 | |
| 2023-12-31 | $228.02M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $254.26M 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $296.11M 10-Q · filed 2024-10-29 | |
| 2023-03-31 | $328.47M 10-Q · filed 2024-07-30 | |
| 2022-12-31 | $253.71M 10-K · filed 2026-02-23 | |
| 2022-09-30 | $561.29M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $637.27M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $329.44M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $388.10M 10-K · filed 2024-02-23 | |
| 2021-09-30 | $391.02M 10-Q · filed 2022-11-14 | $391.26M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$566.50M 10-Q · filed 2022-11-14 | $5.00M 10-Q · filed 2021-07-21 |
| 2021-03-31 | -$521.83M 10-Q · filed 2022-08-15 | $5.00M 10-Q · filed 2021-05-24 |
| 2020-12-31 | -$330.05M 10-K · filed 2023-03-16 | $5.00M 10-K · filed 2021-03-30 |
| 2020-09-30 | -$204.37M 10-Q · filed 2021-11-15 | $5.00M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$147.75M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | -$88.71M 10-K · filed 2023-03-16 | |
| 2018-12-31 | -$55.97M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |